(MENAFN- ProactiveInvestors)
Limited () has been granted an ASX trading halt in relation to European sales of its Mute over-the-counter snoring product.
The halt will last until the earlier of the announcement being made or the start of trade on Monday 18th May 2015.
In April the company expand its Australian wholesale pharmacy distribution footprint with Sigma Pharmaceuticals Limited () to include Mute.
Proactive Investors Australia is the market leader in producing news articles and research reports on ASX emerging companies with distribution in Australia UK North America and Hong Kong / China.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.